000			01951 a2200505 4500
005			20250513055501.0
264		0	_c19940825
008			199408s 0 0 eng d
022			_a0732-183X
024	7		_a10.1200/JCO.1994.12.8.1630 _2doi
040			_aNLM _beng _cNLM
100	1		_aMuss, H B
245	0	0	_aTamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cAug 1994
300			_a1630-8 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdministration, Oral
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aBone Neoplasms _xdrug therapy
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLiver Neoplasms _xdrug therapy
650	0	4	_aMedroxyprogesterone Acetate _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aProspective Studies
650	0	4	_aRegression Analysis
650	0	4	_aSoft Tissue Neoplasms _xdrug therapy
650	0	4	_aSurvival Analysis
650	0	4	_aTamoxifen _xadministration & dosage
700	1		_aCase, L D
700	1		_aAtkins, J N
700	1		_aBearden, J D
700	1		_aCooper, M R
700	1		_aCruz, J M
700	1		_aJackson, D V
700	1		_aO'Rourke, M A
700	1		_aPavy, M D
700	1		_aPowell, B L
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 12 _gno. 8 _gp. 1630-8
856	4	0	_uhttps://doi.org/10.1200/JCO.1994.12.8.1630 _zAvailable from publisher's website
999			_c8040003 _d8040003